Skip to main content
. 2022 Dec 12;12:1042493. doi: 10.3389/fonc.2022.1042493

Figure 2.

Figure 2

Pooled results regarding the tumor clinical-pathological features and long-term prognosis between DCCA and PDCA. (A) Preoperative jaundice. (B) Preoperative stenting. (C) R0 rate. (D) Lymph node metastasis. (E) Vascular invasion. (F) Neural invasion. (G) Tumor size. (H) Postoperative morbidities. (I) Postoperative biliary fistula. (J) Postoperative pancreatic fistula. (K) Mortalities. (L) Overall survival. (M) Disease-free survival. DCCA, distal cholangiocarcinoma; PDCA, pancreatic ductal adenocarcinoma.